<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(10)</volume><submitter>Katz BE</submitter><pubmed_abstract>Retinoids and alpha hydroxy acids differ in mechanism of action for treatment of photodamage, but concurrent use may produce a synergistic effect by combining retinoid-induced normalization of cellular differentiation with alpha hydroxy acid-induced exfoliation (in hydrophilic areas) and enhanced dermal and epidermal hydration. A recent bioengineered molecule, ethyl lactyl retinoate (alpha hydroxy acid retinoid conjugate), is the first to deliver alpha hydroxy acids and retinoids together in a hydrolysis-based time-released fashion. This could improve efficacy while minimizing irritation commonly associated with retinoid use. An eight-week clinical study was conducted to examine the efficacy and tolerability of this formulation; 25 women aged 54.1 ±8.9 years (mean ± SD) with moderate-to-se</pubmed_abstract><journal>The Journal of clinical and aesthetic dermatology</journal><pagination>21-6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4633208</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Tolerability and Efficacy of a Three-product Anti-aging Treatment Regimen in Subjects with Moderate-to-severe Photodamage.</pubmed_title><pmcid>PMC4633208</pmcid><pubmed_authors>McHugh L</pubmed_authors><pubmed_authors>Katz BE</pubmed_authors><pubmed_authors>Lewis J</pubmed_authors><pubmed_authors>Pellegrino A</pubmed_authors><pubmed_authors>Popescu L</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Tolerability and Efficacy of a Three-product Anti-aging Treatment Regimen in Subjects with Moderate-to-severe Photodamage.</name><description>Retinoids and alpha hydroxy acids differ in mechanism of action for treatment of photodamage, but concurrent use may produce a synergistic effect by combining retinoid-induced normalization of cellular differentiation with alpha hydroxy acid-induced exfoliation (in hydrophilic areas) and enhanced dermal and epidermal hydration. A recent bioengineered molecule, ethyl lactyl retinoate (alpha hydroxy acid retinoid conjugate), is the first to deliver alpha hydroxy acids and retinoids together in a hydrolysis-based time-released fashion. This could improve efficacy while minimizing irritation commonly associated with retinoid use. An eight-week clinical study was conducted to examine the efficacy and tolerability of this formulation; 25 women aged 54.1 ±8.9 years (mean ± SD) with moderate-to-se</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Oct</publication><modification>2025-04-22T14:27:48.448Z</modification><creation>2019-03-27T02:01:21Z</creation></dates><accession>S-EPMC4633208</accession><cross_references><pubmed>26557215</pubmed></cross_references></HashMap>